The prognostic determinants of gastric cancer treatment outcome in Omani Arab patients

Oncology

Volumn 70, Issue 2, 2006, Pages 90-96

  Al Moundhri, M S ^a   Al Bahrani, B ^b   Burney, I A ^a   Nirmala, V ^a   Al Madhani, A ^c   Al Mawaly, K ^a   Al Nabhani, M ^a   Thomas, V ^a   Ganguly, S S ^a   Grant, C S ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b ROYAL HOSPITAL   (Oman)

^c Sohar Hospital   (Oman)

Author keywords

Gastric cancer; Stomach

Indexed keywords

ADOLESCENT; ADULT; AGED; ARAB; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; EARLY DIAGNOSIS; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OMAN; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; STOMACH ULCER; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; TREATMENT OUTCOME; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ARABS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OMAN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33646796361     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092584     Document Type: Article

References (54)

1. Roukos DH: Current Status and future perspectives in gastric cancer management. Cancer Treat Rev 2000;26:243-255.
2. Cancer Incidence in Oman. Ministry of Health, Sultanate of Oman, 2002, pp 28-31.
3. Tsugane S: Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005;96:1-6.
4. Gonzalez CA: Vegetable, fruit and cereal consumption and gastric cancer risk. IARC Sci Publ 2002;156:79-83.
5. Kelley JR, Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1-9.
6. Nishimoto IN, Hamada GS, Kowalski LP, et al: Risk factors for stomach cancer in Brazil. I. A case-control study among non-Japanese Brazilians in Sao Paulo. Jpn J Clin Oncol 2002;32:277-283.
7. Gamboa-Dominguez A, Dominguez-Fonseca C, Chavarri-Guerra Y, et al: E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival. Hum Pathol 2005;36:29-35.
8. Troost E, Hold GL, Smith MG, et al: The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk. Can J Gastroenterol 2003;17(suppl B):8B-12B.
9. Yao JC, Tseng JF, Worah S, et al: Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years. J Clin Oncol 2005;23:3094-3103.
10. Gill S, Shah A, Le N, et al: Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol 2003;21:2070-2076.
11. Verdecchia A, Mariotto A, Gatta G, et al: Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003;39:1603-1609.
12. Adachi Y, Yasuda K, Inomata M, et al: Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 2000;89:1418-1424.
13. Giuliani A, Caporale A, Di Bari M, et al: Maximum gastric cancer diameter as a prognostic indicator: univariate and multivariate analysis. J Exp Clin Cancer Res 2003;22:531-538.
14. Hassan HA, Sharma VK, Raufman JP: Changing trends in gastric carcinoma at a university medical center: a twelve-year retrospective analysis. J Clin Gastroenterol 2001;32:37-40.
15. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the 'different disease' hypothesis. Cancer 2000;88:921-932.
16. Kunisaki C, Shimada H, Takahashi M, et al: Prognostic factors in early gastric cancer. Hepatogastroenterology 2001;48:294-298.
17. Skoropad V, Berdov B, Zagrebin V: Clinicopathological features and outcome of surgical treatment of 149 patients with early (pT1) gastric cancer. Onkologie 2005;28:247-252.
18. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-730.
19. Sasako M: Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003;21:274s-275s.
20. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
21. Greene FLP, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M: AJCC Cancer Staging Handbook. Berlin, Springer, 2002.
22. Nishi M, Omori Y, Miwa K: Japanese Classification of Gastric Carcinoma. Tokyo, Kanehara, 1995.
23. Koong HN, Chan HS, Nambiar R, et al: Gastric cancers in Singapore: poor prognosis arising from late presentation. Aust NZ J Surg 1996;66:813-815.
24. Yokota T, Ishiyama S, Saito T, et al: Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol 2004;39:380-384.
25. Vaquerano J, Esemuede N, Odocha O, Leffall LD: Gastric carcinoma in African Americans: a 10 year single center analysis. In Vivo 1996;10:233-235.
26. Dicken BJ, Saunders LD, Jhangri GS, et al: Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol 2004;11:629-635.
27. Thong-Ngam D, Tangkijvanich P, Mahachai V, Kullavanijaya P: Current status of gastric cancer in Thai patients. J Med Assoc Thai 2001;84:475-482.
28. Kandasami P, Tan WJ, Norain K: Gastric cancer in Malaysia: the need for early diagnosis. Med J Malaysia 2003;58:758-762.
29. Noguchi Y, Yoshikawa T, Tsuburaya A, et al: Is gastric carcinoma different between Japan and the United States? Cancer 2000;89:2237-2246.
30. Tsubono Y, Hisamichi S: Screening for gastric cancer in Japan. Gastric Cancer 2000;3:9-18.
31. Nomura E, Tsukuma H, Ajiki W, Oshima A: Population-based study of relationship between hospital surgical volume and 5-year survival of stomach cancer patients in Osaka, Japan. Cancer Sci 2003;94:998-1002.
32. Bonenkamp JJ, van de Velde CJ, Kampschoer GH, et al: Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients. World J Surg 1993;17:410-415.
33. Inoue K, Nakane Y, Michiura T, et al: Trends in long-term survival following surgery for gastric cancer: a single institution experience. Oncol Rep 2004;11:459-464.
34. Stemmermann GN, Fenoglio-Preiser C: Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precursors to a preventable cancer. Pathology 2002;34:494-503.
35. Yao JC, Schnirer II, Reddy S, et al: Effects of sex and racial/ethnic group on the pattern of gastric cancer localization. Gastric Cancer 2002;5:208-212.
36. Zhan YQ, Sun XW, Li W, et al: Multivariate prognostic analysis in gastric carcinoma patients after radical operation. Ai Zheng 2005;24:596-599.
37. Kim DY, Joo JK, Ryu SY, et al: Clinicopathological characteristics of patients with proximal third gastric carcinoma. Acta Chir Belg 2004;104:677-682.
38. Inoue K, Nakane Y, Michiura T, et al: Histopathological grading does not affect survival after R0 surgery for gastric cancer. Eur J Surg Oncol 2002;28:633-636.
39. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T: Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002;9:278-286.
40. Hartgrink HH, van de Velde CJH, Putter H, et al: Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 2004;22:2069-2077.
41. Kappas AM, Fatouros M, Roukos DH: Is it time to change surgical strategy for gastric cancer in the United States? Arm Surg Oncol 2004;11:727-730.
42. Shiu MH, Moore E, Sanders M, et al: Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis. Arch Surg 1987;122:1347-1351.
43. Hayes N, Ng EK, Raimes SA, et al: Total gastrectomy with extended lymphadenectomy for 'curable' stomach cancer: experience in a non-Japanese Asian center. J Am Coll Surg 1999;188:27-32.
44. Carboni F, Lepiane P, Santoro R, et al: Extended multiorgan resection for T4 gastric carcinoma: 25-year experience. J Surg Oncol 2005;90:95-100.
45. Kobayashi A, Nakagohri T, Konishi M, et al: Aggressive surgical treatment for T4 gastric cancer. J Gastrointest Surg 2004;8:464-470.
46. Bonenkamp JJ, Hermans J, Sasako M, et al: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908-914.
47. Cuschieri A, Weeden S, Fielding J, et al: Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:1522-1530.
48. National Comprehensive Cancer Network Web site. http://www.nccn.org/.
49. Kattan MW, Karpeh MS, Mazumdar M, et al: Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003;21:3647-3650.
50. Fujii M, Sasaki J, Nakajima T: State of the art in the treatment of gastric cancer: from the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999;2:151-157.
51. Macdonald JS: Adjuvant therapy for gastric cancer. Semin Oncol 2003;30:19-25.
52. Macdonald JS: Treatment of localized gastric cancer. Semin Oncol 2004;31:566-573.
53. Van Cutsem E: The treatment of advanced gastric cancer: new findings on the activity of the taxanes. Oncologist 2004;9:9-15.
54. Oluwasola AO, Ogunbiyi JO: Gastric cancer: aetiological, clinicopathological and management patterns in Nigeria. Niger J Med 2003;12:177-186.